去甲肾上腺素升高血压对合并既往动脉高压的脓毒性休克患者微循环的影响
该研究为前瞻性、非盲法干预研究,纳入3个ICU中40例脓毒性休克成人患者(合并既往动脉高压者20例,无动脉高压对照20例,按年龄配对)。在基线(时间0)后增加去甲肾上腺素剂量使平均动脉压升至85-90 mmHg,再采集测量(时间1)。结果显示两组心脏指数均显著升高、乳酸均轻度显著下降;灌注血管比例、灌注血管密度和微循环血流指数在两组均显著改善,但组间及组间×时间交互均无显著差异。结论认为升高平均动脉压可改善舌下微循环小血管密度和血流,且该改善在合并与不合并既往动脉高压的患者中均出现。
要点
- 脓毒性休克患者增加去甲肾上腺素剂量使平均动脉压升至85-90 mmHg后,灌注血管比例在对照组从57.2±14%升至66±14.8%,在动脉高压组从61.4±12.3%升至70.8±7.1%(时间点p<0.001,组间p=0.29)。
- 灌注血管密度在对照组从15.6±4 mm/mm升至18.6±4.5 mm/mm,在动脉高压组从16.4±3.5 mm/mm升至19.1±3 mm/mm(时间点p<0.001,组间p=0.51)。
- 微循环血流指数在对照组从2.1±0.6升至2.4±0.6,在动脉高压组从2.1±0.5升至2.6±0.2(时间点p=0.002,组间p=0.71)。
- 两组在升高平均动脉压后心脏指数均显著升高,乳酸均轻度但显著下降。
- 合并既往动脉高压与不合并者在微循环改善程度上无显著差异(组间×时间交互p值分别为0.85、0.70、0.45)。
适用人群与场景
- 年龄大于18岁、脓毒性休克持续至少6小时、已镇静并接受机械通气的患者。
- 研究在3个ICU中纳入患者,合并既往系统性动脉高压者与无动脉高压对照按年龄配对。
诊断标准与关键阈值
- 脓毒性休克持续至少6小时。
- 已镇静并接受机械通气。
处置流程与药物剂量
- 在获取全身及微循环基线血流动力学变量(时间0)后,增加去甲肾上腺素剂量以将平均动脉压升至85-90 mmHg,再采集测量(时间1)。
研究设计与关键结果
- 研究设计为前瞻性、非盲法干预研究,在2家教学医院的3个ICU进行,纳入40例患者(每组20例),两组年龄无显著差异。
- 升高平均动脉压后两组心脏指数均显著升高,乳酸均轻度但显著下降。
- 灌注血管比例:对照组57.2±14%升至66±14.8%,动脉高压组61.4±12.3%升至70.8±7.1%;组间p=0.29,时间点p<0.001,组间×时间交互p=0.85。
- 灌注血管密度:对照组15.6±4 mm/mm升至18.6±4.5 mm/mm,动脉高压组16.4±3.5 mm/mm升至19.1±3 mm/mm;组间p=0.51,时间点p<0.001,组间×时间交互p=0.70。
- 微循环血流指数:对照组2.1±0.6升至2.4±0.6,动脉高压组2.1±0.5升至2.6±0.2;组间p=0.71,时间点p=0.002,组间×时间交互p=0.45。
证据类型、等级与局限
- 证据类型:前瞻性、非盲法、干预性研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,在脓毒性休克患者中用去甲肾上腺素升高平均动脉压可改善舌下微循环小血管密度和血流,且该改善在合并既往动脉高压与不合并者中均出现。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: To assess whether an increase in mean arterial pressure in patients with septic shock and previous systemic arterial hypertension changes microcirculatory and systemic hemodynamic variables compared with patients without arterial hypertension (control).
DESIGN: Prospective, nonblinded, interventional study.
SETTING: Three ICUs in two teaching hospitals.
PATIENTS: After informed consent, we included patients older than 18 years with septic shock for at least 6 hours, sedated, and under mechanical ventilation. We paired patients with and without arterial hypertension by age.
INTERVENTIONS: After obtaining systemic and microcirculation baseline hemodynamic variables (time 0), we increased noradrenaline dose to elevate mean arterial pressure up to 85-90 mm Hg before collecting a new set of measurements (time 1).
MEASUREMENTS AND MAIN RESULTS: We included 40 patients (20 in each group). There was no significant difference in age between the groups. After the rise in mean arterial pressure, there was a significant increase in cardiac index and a slight but significant reduction in lactate in both groups. We observed a significant improvement in the proportion of perfused vessels (control: 57.2 ± 14% to 66 ± 14.8%; arterial hypertension: 61.4 ± 12.3% to 70.8 ± 7.1%; groups: p = 0.29; T0 and T1: p < 0.001; group and time interaction: p = 0.85); perfused vessels density (control: 15.6 ± 4 mm/mm to 18.6 ± 4.5 mm/mm; arterial hypertension: 16.4 ± 3.5 mm/mm to 19.1 ± 3 mm/mm; groups: p = 0.51; T0 and T1: p < 0.001; group and time interaction: p = 0.70), and microcirculatory flow index (control: 2.1 ± 0.6 to 2.4 ± 0.6; arterial hypertension: 2.1 ± 0.5 to 2.6 ± 0.2; groups: p = 0.71; T0 and T1: p = 0.002; group and time interaction: p = 0.45) in both groups.
CONCLUSIONS: Increasing mean arterial pressure with noradrenaline in septic shock patients improves density and flow in small vessels of sublingual microcirculation. However, this improvement occurs both in patients with previous arterial hypertension and in those without arterial hypertension.
参考来源
- Fiorese Coimbra KT, de Freitas FGR, Bafi AT, et al. Effect of Increasing Blood Pressure With Noradrenaline on the Microcirculation of Patients With Septic Shock and Previous Arterial Hypertension. Crit Care Med. 2019. PMID: 31094744. doi:10.1097/CCM.0000000000003795
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。